Relevant bibliographies by topics / Anti-hepatitis-B

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Anti-hepatitis-B'

Author: Grafiati
Published: 7 June 2025
Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Anti-hepatitis-B.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Anti-hepatitis-B"

1

Aghayeva, S. Сh, and A. A. Hidayatov. "THE IMPACT OF OCCULT HEPATITIS B INFECTION ON THE COURSE OF CHRONIC HEPATITIS C TREATMENT WITH DIRECT-ACTING ANTIVIRALS." Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії 22, no. 1 (2022): 4–8. http://dx.doi.org/10.31718/2077-1096.22.1.4.

Full text
Abstract:
The prevalence of viral hepatitis B and C in Azerbaijan is 3.2% and 4.3% respectively. The incidence of occult hepatitis B has not been previously studied. The purpose of this study is to assess the prevalence of occult hepatitis B infection among patients with chronic hepatitis C, as well as to assess the impact of occult hepatitis B on the progression of liver disease and to identify the likelihood of viral/clinical reactivation of occult hepatitis B during treatment with direct-acting antiviral drugs. Results. The study included 164 patients with chronic hepatitis C with the absence of over
APA, Harvard, Vancouver, ISO, and other styles
2

Rakhmani, Dinna, Aini Luthfiah Hayati, and Tini Elyn Herlina. "PROFIL ANTI-HBS PADA MAHASISWA TEKNOLOGI LABORATORIUM MEDIS POLTEKKES KEMENKES BANJARMASIN." Medika Kartika Jurnal Kedokteran dan Kesehatan, Volume 5 No 3 (September 29, 2022): 265–74. http://dx.doi.org/10.35990/mk.v5n3.p265-274.

Full text
Abstract:
Hepatitis B adalah infeksi yang disebabkan oleh virus Hepatitis B dan menyerang jaringan hati. Virus Hepatitis B dapat menular melalui darah dan cairan tubuh penderita. Infeksi Hepatitis B dapat dicegah dengan melakukan vaksinasi. Kekebalan tubuh terhadap infeksi virus Hepatitis B ditandai dengan adanya kandungan Anti-HBs. Anti-HBs merupakan antibodi protektif terhadap infeksi virus Hepatitis B. Kadar protektif Anti-HBs terhadap infeksi virus Hepatitis B sebesar ≥10 mIU/mL. Penelitian ini bertujuan untuk mengetahui profil anti-HBs pada mahasiswa Teknologi Laboratorium Medis Poltekkes Kemenkes
APA, Harvard, Vancouver, ISO, and other styles
3

Balegha, Augustine Ngmenemandel. "Factors influencing the utilisation of anti-HBs titre testing services among nursing students in Northwest Ghana: A cross-sectional study." PLOS Global Public Health 4, no. 4 (2024): e0003160. http://dx.doi.org/10.1371/journal.pgph.0003160.

Full text
Abstract:
Understanding the impact of hepatitis B testing, vaccination, the number of vaccine doses, and socio-demographics on post-vaccination anti-HBs titre testing, is essential for hepatitis B prevention. The aim of the study was to determine the prevalence of hepatitis B testing, hepatitis B vaccination, number of vaccine doses received, socio-demographic characteristics, and their impact on anti-HBs titre testing among nursing students in Northwest Ghana. A stratified sample of 402 nursing students from Wa and Lawra nursing colleges in Ghana’s Upper West Region was surveyed in November 2020 using
APA, Harvard, Vancouver, ISO, and other styles
4

Md. Nazmul Islam, Md. Shohanur Rahaman, Sadia Islam, et al. "Serological profile and interpretation of different hepatitis B virus marker." World Journal of Biology Pharmacy and Health Sciences 14, no. 3 (2023): 213–18. http://dx.doi.org/10.30574/wjbphs.2023.14.3.0265.

Full text
Abstract:
Hepatitis B virus (HBV) infections are a global public health problem. Chronic hepatitis B (CHB) infection is associated with an increased risk of cirrhosis, hepatic decompensation and hepatocellular carcinoma (HCC). In virus-infected liver cells, HBsAg is produced in excess and secreted into the blood, where it serves as a marker for active infection and infectivity. Currently, recombinant HBsAg is used for HBV vaccination, and the development of antibody to HBsAg is typically associated with protective immunity. The likelihood of developing CHB is related to the age at which infection is acq
APA, Harvard, Vancouver, ISO, and other styles
5

Md., Nazmul Islam, Shohanur Rahaman Md., Islam Sadia, et al. "Serological profile and interpretation of different hepatitis B virus marker." World Journal of Biology Pharmacy and Health Sciences 14, no. 3 (2023): 213–18. https://doi.org/10.5281/zenodo.8318100.

Full text
Abstract:
Hepatitis B virus (HBV) infections are a global public health problem. Chronic hepatitis B (CHB) infection is associated with an increased risk of cirrhosis, hepatic decompensation and hepatocellular carcinoma (HCC). In virus-infected liver cells, HBsAg is produced in excess and secreted into the blood, where it serves as a marker for active infection and infectivity. Currently, recombinant HBsAg is used for HBV vaccination, and the development of antibody to HBsAg is typically associated with protective immunity. The likelihood of developing CHB is related to the age at which infection is acq
APA, Harvard, Vancouver, ISO, and other styles
6

Honorati, M. C., A. Palareti, P. Dolzani, and A. Facchini. "Planning for anti-hepatitis B revaccination." Immunology Letters 56 (May 1997): 289. http://dx.doi.org/10.1016/s0165-2478(97)86162-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Honorati, M. "Planning for anti-hepatitis B revaccination." Immunology Letters 56, no. 1-3 (1997): 289. http://dx.doi.org/10.1016/s0165-2478(97)88000-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Z Arthamin, Maimun. "MUTANT HBV INFECTION ON aa143 (T143S)." INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 15, no. 2 (2018): 68. http://dx.doi.org/10.24293/ijcpml.v15i2.949.

Full text
Abstract:
Lebih dari satu dasawarsa lalu, segi penting mutan virus hepatitis B (HBV) telah teralihkan dari sejumlah kenyataan teoriyang tidak diketahui menjadi faktor untuk dipertimbangkan saat mendiagnosis penyakit. Laporan mutan virus hepatitis B (HBsAg)dalam petentu “suatu” telah diperkenalkan. Mutan diisolasi dari penderita seorang laki-laki tanpa gejala berumur 25 tahun, yangditemukan positif HBsAg tetap, positif untuk antibodi permukaan anti-hepatitis B(anti-HBs) dan negatif untuk kedua penutuplengkap virus hepatitis B antigen (HbeAg) serta penutup lengkap anti-hepatitis B antibodi (anti-HBe). Rea
APA, Harvard, Vancouver, ISO, and other styles
9

MOSSONG, J., L. PUTZ, S. PATINY, and F. SCHNEIDER. "Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg." Epidemiology and Infection 134, no. 4 (2006): 808–13. http://dx.doi.org/10.1017/s0950268805005789.

Full text
Abstract:
A prospective seroepidemiological survey was carried out in Luxembourg in 2000–2001 to determine the antibody status of the Luxembourg population against hepatitis A virus (HAV) and hepatitis B virus (HBV). One of the objectives of this survey was to assess the impact of the hepatitis B vaccination programme, which started in May 1996 and included a catch-up campaign for all adolescents aged 12–15 years. Venous blood from 2679 individuals was screened for the presence of antibodies to HAV antigen and antibodies to hepatitis B surface antigen (anti-HBs) using an enzyme immunoassay. Samples posi
APA, Harvard, Vancouver, ISO, and other styles
10

Caballero, L. Requena, C. Requena Caballero, I. Requena Caballero, et al. "Prevalence and risk factors of hepatitis B in Spanish prostitutes." Epidemiology and Infection 99, no. 3 (1987): 767–74. http://dx.doi.org/10.1017/s0950268800066620.

Full text
Abstract:
SUMMARYEighty prostitutes wore tested by solid-phase radioimmunoassay for serum markers of hepatitis B virus (HBV). Of 8 (10%) with hepatitis B surface antigen (HBsAg), 6 (75%) also had hepatitis Be antigen (HBeAg). Antibodies to HBsAg (anti-HBs) and to hepatitis B core antigen (anti-HBc) were found in 52 (65%). Antibodies to HBeAg (anti-HBe) were positive in 32 (40%). Anti-HBc alone was found in 5 (6%) and anti-HBs alone in 2 (2%). Sixty-seven (84%) were positive for at least one HBV marker and 13 (16%) were still susceptible to infection. Hepatitis B markers were more prevalent in prostitute
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Anti-hepatitis-B"

1

Oliveira, Laura Ferreira. "Persistência de anticorpos protetores após sete anos de imunização contra hepatite b em lactentes em Goiânia – GO." Universidade Federal de Goiás, 2015. http://repositorio.bc.ufg.br/tede/handle/tede/5433.

Full text
Abstract:
Submitted by Marlene Santos (marlene.bc.ufg@gmail.com) on 2016-04-04T20:19:20Z No. of bitstreams: 2 Dissertação - Laura Ferreira Oliveira - 2015.pdf: 1240339 bytes, checksum: 93a5f81eb7e7be949c0fb3fbffedb6c9 (MD5) license_rdf: 19874 bytes, checksum: 38cb62ef53e6f513db2fb7e337df6485 (MD5)<br>Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2016-04-05T11:08:20Z (GMT) No. of bitstreams: 2 Dissertação - Laura Ferreira Oliveira - 2015.pdf: 1240339 bytes, checksum: 93a5f81eb7e7be949c0fb3fbffedb6c9 (MD5) license_rdf: 19874 bytes, checksum: 38cb62ef53e6f513db2fb7e337df6485 (
APA, Harvard, Vancouver, ISO, and other styles
2

Keilhammer, Stefan [Verfasser], and Wolfgang [Akademischer Betreuer] Jilg. "Der Einfluss von Zytokinen, Anti-HBs-spezifischen T-Zellen und Anti-HBs auf Hepatitis B produzierende Zellen: Beobachtungen an einem Zellkultursystem als Model der chronischen Hepatitis B / Stefan Keilhammer. Betreuer: Wolfgang Jilg." Regensburg : Universitätsbibliothek Regensburg, 2016. http://d-nb.info/1095233335/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Keilhammer, Stefan Verfasser], and Wolfgang [Akademischer Betreuer] [Jilg. "Der Einfluss von Zytokinen, Anti-HBs-spezifischen T-Zellen und Anti-HBs auf Hepatitis B produzierende Zellen: Beobachtungen an einem Zellkultursystem als Model der chronischen Hepatitis B / Stefan Keilhammer. Betreuer: Wolfgang Jilg." Regensburg : Universitätsbibliothek Regensburg, 2016. http://nbn-resolving.de/urn:nbn:de:bvb:355-epub-332721.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Borges, A. L. S. "Avaliação dos níveis de anti-HBs pós booster em crianças, após sete anos do esquema vacinal primário." Universidade Federal de Goiás, 2016. http://repositorio.bc.ufg.br/tede/handle/tede/6488.

Full text
Abstract:
Submitted by Jaqueline Silva (jtas29@gmail.com) on 2016-11-10T17:16:50Z No. of bitstreams: 2 Dissertação - Ana Letícia Soares Borges - 2016.pdf: 2871403 bytes, checksum: 8e6a9f0ded122635cdcd6fc18a864f18 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)<br>Approved for entry into archive by Jaqueline Silva (jtas29@gmail.com) on 2016-11-10T17:17:02Z (GMT) No. of bitstreams: 2 Dissertação - Ana Letícia Soares Borges - 2016.pdf: 2871403 bytes, checksum: 8e6a9f0ded122635cdcd6fc18a864f18 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)<br>Made a
APA, Harvard, Vancouver, ISO, and other styles
5

Fung, Tak-kwan James. "Development of anti-HBs in patients with chronic hepatitis B after liver transplantation using lamivudine prophylaxis the possible role of adoptive immunity transfer /." Click to view the E-thesis via HKUTO, 2003. http://sunzi.lib.hku.hk/hkuto/record/B31980934.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Neto, Gaspar Lisboa. "Influência da infecção pregressa pelo vírus da hepatite B em portadores de hepatite C crônica: análise histológica." Universidade de São Paulo, 2009. http://www.teses.usp.br/teses/disponiveis/5/5134/tde-02072009-095040/.

Full text
Abstract:
INTRODUÇÃO: Os vírus das hepatites B (VHB) e C (VHC) são os principais causadores de hepatopatia crônica em todo mundo. Ambos compartilham vias semelhantes de transmissão. Em pacientes portadores crônicos de VHC com sorologia compatível com infecção pregressa pelo VHB (anti-HBcAg[+] e HBsAg [-]), o VHB DNA residual tem sido detectado por técnicas de biologia molecular altamente sensíveis no soro, em células linfomononucleares de sangue periférico e em hepatócitos (como cccDNA), de forma que o anti-HBcAg tem sido associado a pior prognóstico, tanto histológico quanto terapêutico. OBJETIVOS: Ana
APA, Harvard, Vancouver, ISO, and other styles
7

Bitencourt, Hellen Tayaná Oliveira. "Pesquisa e caracterização da hepatite B oculta em doadores de sangue do estado do Amapá." Universidade de São Paulo, 2017. http://www.teses.usp.br/teses/disponiveis/17/17155/tde-07062017-161019/.

Full text
Abstract:
Introdução. A infecção causada pelo vírus da hepatite B (HBV) é um dos agravos de maior prevalência no mundial. Segundo a Organização Mundial da Saúde (OMS) existem mais de 350 milhões de portadores crônicos da doença. A infecção pelo HBV é rotineiramente identificada quando há a presença do HBsAg circulante. Entretanto, em alguns casos o HBV-DNA tem sido detectado em indivíduos HBsAg negativos, positivos ou negativos para anti-HBc e anti-HBs. Essa apresentação sorológica e molecular é denominada infecção oculta pelo HBV (OBI). Geralmente a concentração do HBV-DNA no soro será abaixo de 200 UI
APA, Harvard, Vancouver, ISO, and other styles
8

Faupel, Fabian Matthias [Verfasser]. "Die Bedeutung von Anti-präS2-Antikörpern in der Diagnostik des Hepatitis-B-Virus / Fabian Matthias Faupel." Gießen : Universitätsbibliothek, 2011. http://d-nb.info/1061195570/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Alfaiate, Dulce. "Study of the interplay between hepatitis B and hepatitis delta viruses and evaluation of investigational anti-HDV immuno-modulators in superinfection cell culture models." Thesis, Lyon 1, 2015. http://www.theses.fr/2015LYO10123/document.

Full text
Abstract:
La surinfection par HDV/ HBV est la forme la plus grave d'hépatite virale chronique et affecte entre 15-20 millions de patients au niveau mondial. HDV n'est pas susceptible aux traitements anti-HBV et le taux de réponse à l'IFNα est &lt;25%. Malgré une progression plus rapide de la maladie hépatique, la majorité des patients présente une suppression de la réplication du HBV. Les détails des interactions entre HDV, HBV et le système immunitaire inné des cellules infectées restent inconnus. Les objectifs de ces travaux de thèse ont été: i) l'étude de l'infection par HDV et son interaction avec l
APA, Harvard, Vancouver, ISO, and other styles
10

Fung, Tak-kwan James, and 馮德焜. "Development of anti-HBs in patients with chronic hepatitis B after liver transplantation using lamivudine prophylaxis: the possible role of adoptive immunity transfer." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2003. http://hub.hku.hk/bib/B31980934.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Anti-hepatitis-B"

1

Forman, Gary. The synthesis of potential anti-hepatitis B virus nucleotides. University of Birmingham, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Körfer, Norbert. Anti-HBs-Titerverlauf nach Hepatitis-B-Auffrischungsimpfung. 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

(Editor), P. Coursaget, and M. J. Tong (Editor), eds. Progress in Hepatitis B Immunization. John Libbey & Co Ltd, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Goergen, Bernd. Die Bedeutung von Hepatitis B Virus PräCore-Mutanten für die Pathogenese der anti-HBeAg positiven, chronischen Hepatitis B. 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Proceedings of an International Symposium on Anti-Viral Agents in Chronic Hepatitis B Virus Infection. Elsevier Science & Technology, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Choi, Eun Kyung, and Young-Gyung Paik. ‘A vaccine for the nation’: South Korea’s development of a hepatitis B vaccine and national prevention strategy focused on newborns. Manchester University Press, 2017. http://dx.doi.org/10.7228/manchester/9781526110886.003.0005.

Full text
Abstract:
For several decades South Korea has been recognised as a country in which hepatitis B is endemic, but it has also become famous for its controlled hepatitis epidemic, using a well-organised vaccination plan.The social determinants surrounding the vaccination plan have not been studied, however. In the 1980s, the hepatitis issue was a major concern in Korea, involving various actors, including medical doctors, the government, foreign scholars, and international institutions. While the domestic production of hepatitis B vaccines and the vaccination campaigns focused on newborns, combined with ex
APA, Harvard, Vancouver, ISO, and other styles
7

Winter, Rebecca J., and Margaret E. Hellard. Drug Use in Prisoners and Hepatitis. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.003.0009.

Full text
Abstract:
A corollary of the high proportion of people who inject drugs cycling through prisons worldwide is the accompanying high prevalence of viral hepatitis, particularly hepatitis C (HCV). Prisons have the potential to either escalate or interrupt the transmission of viral hepatitis: prisons that do not provide access to even basic prevention programs are high-risk environments for viral hepatitis transmission. In contrast, prisons can also reduce prevalence through testing and treatment programs. This chapter provides an overview of the global prevalence and incidence of HCV and hepatitis B (HBV)
APA, Harvard, Vancouver, ISO, and other styles
8

Burchell, Ann, and Eduardo Franco1. The impact of immunization on cancer control: the example of HPV vaccination. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199550173.003.0006.

Full text
Abstract:
Chapter 6 reviews briefly the role of infections as causal agents in cancer, describes anti-hepatitis B virus (HBV) immunization as the first cancer vaccine paradigm, and finally focuses on the latest paradigm of prophylactic vaccination against human papillomavirus (HPV) infection as the new front in cancer prevention.
APA, Harvard, Vancouver, ISO, and other styles
9

Berden, Jo H. M., and Jack F. M. Wetzels. Immunological investigation of the patient with renal disease. Edited by Christopher G. Winearls. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0017.

Full text
Abstract:
Laboratory techniques (electrophoresis, indirect immunofluorescence, ELISA, and immunoblotting) required for immunological investigation of the patient with renal disease are described. Renal disease-related aspects of immunoglobulins (immunoglobulin A, paraproteins, cryoglobulins), complement, antinuclear antibodies, anti-C1q antibodies, antineutrophil cytoplasmic antibodies, anti-glomerular basement membrane antibodies, antipodocyte antibodies, antiphospholipid antibodies, and antimicrobial responses (streptococci, hepatitis C, hepatitis B) are reviewed. Laboratory assays which evaluate the
APA, Harvard, Vancouver, ISO, and other styles
10

Cattran, Daniel C., and Heather N. Reich. Membranous glomerulonephritis. Edited by Neil Turner. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0061_update_001.

Full text
Abstract:
Membranous glomerulonephritis (MGN) usually presents as nephrotic syndrome, which may be severe. It is primarily a disease of adults, men more than women, with a peak incidence in the fourth and fifth decades. It is hoped that proven tests for the characteristic anti-PLA2R antibodies of primary MGN may become established, but the diagnosis currently rests on renal biopsy showing characteristic subepithelial granular immune deposits. These usually contain immunoglobulin G4 and complement. Other patterns may suggest secondary causes of MGN. Secondary membranous nephropathy occurs in lupus and so
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Anti-hepatitis-B"

1

Possehl, Ch, R. Repp, K. H. Heermann, E. Korec, A. Uy, and W. H. Gerlich. "Absence of free core antigen in anti-HBc negative viremic hepatitis B carriers." In Chronically Evolving Viral Hepatitis. Springer Vienna, 1992. http://dx.doi.org/10.1007/978-3-7091-5633-9_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Thanavala, Yasmin M., Angela Bond, Richard Tedder, Frank C. Hay, and Ivan M. Roitt. "Monoclonal Internal Image Anti-Idiotypic Antibodies of Hepatitis B Surface Antigen." In Investigation and Exploitation of Antibody Combining Sites. Springer US, 1985. http://dx.doi.org/10.1007/978-1-4684-5006-4_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kato, Naoya, Suzane Kioko Ono-Nita, and Masao Omata. "New Anti-Virals Against Wild-Type and Lamivudine-Resistant Hepatitis B Virus." In Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma. Springer Japan, 2004. http://dx.doi.org/10.1007/978-4-431-53977-3_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bogusławska-Jaworska, J., E. Gorczyńska, H. Seyfried, A. Gładysz, and M. Zalewska. "Passive and Active Anti-Hepatitis B Immunization of Children with Hematological Malignancies." In Acute Leukemias. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71213-5_93.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kennedy, Ronald C., and Gordon R. Dreesman. "Antigen Mimicry by Anti-Idiotype Antibodies That Recognize a Common Anti-Hepatitis B Surface Antigen Idiotype." In Advances in Experimental Medicine and Biology. Springer US, 1985. http://dx.doi.org/10.1007/978-1-4684-7974-4_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gesemann, M., S. Schröder, N. Scheiermann, and C. Maurer. "Kinetics of anti-HBs after hepatitis B vaccination: a comparison of two recombinant and one plasma-derived vaccines." In Chronically Evolving Viral Hepatitis. Springer Vienna, 1992. http://dx.doi.org/10.1007/978-3-7091-5633-9_33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gmelin, K., F. Kurzen, B. Kallinowski, et al. "Follow-up of patients with hepatitis non-A, non-B: incidence and persistence of anti-HCV depend on route of transmission." In Chronically Evolving Viral Hepatitis. Springer Vienna, 1992. http://dx.doi.org/10.1007/978-3-7091-5633-9_48.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Cheng, Y.-C., C.-N. Chang, S.-L. Doong, et al. "2′3′Dideoxy-3′Thiacytidine (SddC) as an Anti-Human Hepatitis B Virus (HBV) and Anti-Human Immunodeficiency Virus (HIV) Agent." In Molecular Aspects of Chemotherapy. Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-662-02740-0_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Budkowska, A., P. Dubreuil, and J. Pillot. "Biologic Significance of Pre-S Antigen and Anti-Pre-S Antibodies in Hepatitis B Virus Infection." In Progress in Vaccinology. Springer New York, 1989. http://dx.doi.org/10.1007/978-1-4612-3508-8_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Petit, Marie-Anne, F. Capel, F. Zoulim, et al. "PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response." In Chronically Evolving Viral Hepatitis. Springer Vienna, 1992. http://dx.doi.org/10.1007/978-3-7091-5633-9_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Anti-hepatitis-B"

1

Kemal, Rahmat Azhari, Huriatul Masdar, Fajri Marindra Siregar, and Dedi Afandi. "Anti-Hepatitis B surface Titer as Indicator in Faculty of Medicine Universitas Riau Hepatitis B Vaccination Program." In The 3rd Green Development International Conference (GDIC 2020). Atlantis Press, 2021. http://dx.doi.org/10.2991/aer.k.210825.073.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Clemens, R., G. Wirl, C. Velten, and H. J. Röthig. "VIRUS SAFETY OF ANTITHROMBIN III CONCENTRATE KYBERNIN P - APROSPECTIVE CLINICAL TRIAL." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644148.

Full text
Abstract:
In 13 healthy male volunteers a prospective clinical trial was performed to evaluate virus safety of the antithrombin III concentrate Kybernin P in regard to hepatitis B, non-A/non-Band HIV transmission. As the volunteers were participants of a pharmacokinetic study they received either a fixed dosage of 1000 units Kybernin P asbolus injection or a dosage of 50 units per kg body weight as short-term infusion. Two different batches of Kybernin P were used.Whereas in all 13 volunteers virussafety in hepatitis non-A/non-B and HAV transmission could be monitored, only those volunteers who were not
APA, Harvard, Vancouver, ISO, and other styles
3

annatou, yakoubou, and tchiakpè nicole. "P366 The interest of anti hepatitis B vaccination at birth." In Faculty of Paediatrics of the Royal College of Physicians of Ireland, 9th Europaediatrics Congress, 13–15 June, Dublin, Ireland 2019. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2019. http://dx.doi.org/10.1136/archdischild-2019-epa.712.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ho, Grace Chup-Hei. "AB0360G DETECTABLE HBV DNA AT TREATMENT BASELINE PREDICTED HEPATITIS B VIRUS REACTIVATION IN INFLAMMATORY ARTHRITIS PATIENTS WITH NEGATIVE HEPATITIS B SURFCE ANTIGEN BUT POSITIVE ANTI-HEPATITIS B CORE ANTIGEN." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.7598.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kipiani, E., M. Butsashvili, G. Kamkamidze, and G. Abashidze. "STUDY OF RISK FACTORS AFFECTING HBV VACCINE EFFICIENCY AMONG CHILDREN IN GEORGIA." In International Trends in Science and Technology. RS Global Sp. z O.O., 2020. http://dx.doi.org/10.31435/rsglobal_conf/30122020/7346.

Full text
Abstract:
In the conditions of mass vaccination of hepatitis B, all over the world, including in Georgia, in the vaccinated population, the numberof those individuals who could not develop Anti-HBs are growing every day. According to the literature, the main reason for the ineffective vaccination of hepatitis B is considered to be an increase in the prevalence of express mutants among the hepatitisB virus population, which is of a similar intensity throughout the world. In parallel with a detailed analysis of literature sources, the scientific article for the first time studied the seroprevalence of Ant
APA, Harvard, Vancouver, ISO, and other styles
6

Huang, Hao, Zhonghua Yang, Guanghui Wang, and Jun Chen. "In vitro anti-hepatitis B virus activity of konjac oligo-glucomannan sulfate." In 2010 3rd International Conference on Biomedical Engineering and Informatics (BMEI). IEEE, 2010. http://dx.doi.org/10.1109/bmei.2010.5640540.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Castro, Ana Rita Motta, Livia Lima, Larissa Bandeira, et al. "Hepatitis B: changes in epidemiological features of Afrodescendant communities in Central Brazil." In XIII Congresso da Sociedade Brasileira de DST - IX Congresso Brasileiro de AIDS - IV Congresso Latino Americano de IST/HIV/AIDS. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/dst-2177-8264-202133p142.

Full text
Abstract:
Introduction: Hepatitis B virus (HBV) infection is still a concern in vulnerable populations. In a study performed by our team in 1999–2003 in two Afro-Brazilian communities, Furnas dos Dionísios (FD) and São Benedito (SB), high prevalence rates of HBV exposure (42.7% and 16.0%, respectively), high susceptibility to HBV (55.3% and 63.0%, respectively) and low HBV vaccination like profile rates (2.0% and 21.0%, respectively) were observed. Objective: In 2015–2016, we reassessed epidemiological and molecular features of HBV in these two communities to verify the impact of health actions adopted
APA, Harvard, Vancouver, ISO, and other styles
8

Seidl, S. "SCREENING PROCEDURES TO PREVENT TRANSMISSION OF HEPATITIS B, NON-A,NON-B, AND AIDS BY BLOOD TRANSFUSION." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644753.

Full text
Abstract:
Although the number of infectious agents capable of being transmitted through blood and blood products is vast, only a few cause problems in recipients of a magnitude which warrants the need for screening tests. The most important agents are Hepatitis B Virus (HBV), Hepatitis non-A,non-B (HNANB) - agents causing posttransfusion hepatitis (PTH) and the human immundeficiency viruses (HIV) responsible for transfusion associated AIDS (TAA).PTH: Prospective studies in open-heart-surgery patients demonstrated a high prevalence (8-17%) *in Spain, Italy, the United States and Israel whereas low percen
APA, Harvard, Vancouver, ISO, and other styles
9

Liang, Kung-Hao. "Dynamic programming for clinical baseline matching and its application to anti-hepatitis B research." In 2016 IEEE 16th International Conference on Bioinformatics and Bioengineering (BIBE). IEEE, 2016. http://dx.doi.org/10.1109/bibe.2016.72.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rossi, L., A. M. Gianregorio, S. Bartolai, L. Lecchini, M. Bendinelli, and F. Panicucci. "IMMUNOLOGIC EVALUATIONOF ITALIAN HAEMOPHILIACS TREATED WITH COMMERCIAL CONCENTRATES." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644146.

Full text
Abstract:
The presence of the antibody to human immunodeficiency virus (HIV) was investigated in 487 serum samples withdrawn from 216 haemophiliacs (186 haemophiliacs A and 30 B) who came to the Pisa Centre between 1977 and 1986. Results show that a considerable proportion of haemophiliacs (15%) were already positive in 1982. In haemophiliacs A, who were treated up to 1983 with concentrates made from US plasma, but from 1984 on began to use concentrates made from Italian plasma, this proportion in 1986 was 16%. In haemophiliacs B who have continued using concentrates from US plasma, the prevalcence rate
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Anti-hepatitis-B"

1

Shen, Feifei, Xiaodan Ren, Haiqiang Liu, and Hewei Zhang. Value of Anti-HBV in Serum Tested by ELISA3 in Diagnosis of Hepatitis B: A Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.10.0051.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chen, Mao-bing, Hua Wang, Qi-han Zheng, Wei-yan Cui, Hua-lan Xu, and Xu-wen Zheng. Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B, A protocol for systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.3.0016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Anti-hepatitis-B' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography